@FiercePharma: New migraine use for Botox could be worth $1B. Article | Follow @FiercePharma
Special Report: Pharma's Biggest Flops. Report
> Bristol-Myers Squibb said FDA approved its hepatitis B treatment Baraclude for patients with a more severe form of liver disease. Report
> The coalition government has abandoned a new provision in the proposed Pharmaceutical Price Regulation Scheme that could have allowed pharmacists to swap a doctor-prescribed branded medicine with a generic substitute in an effort of cost-effectiveness. Story
> Taking statin drugs may lower the risk of colon cancer by 12 percent, according to a meta-analysis covering over 2.5 million people. Article
> A week of global anti-counterfeiting law enforcement coordinated by Interpol led to the shutdown of 290 websites, seizure of 11,000 packages and confiscation of 1 million pills. Report
> Natco Pharma has said that Revlimid-maker Celgene has filed a lawsuit against the Indian company's application for FDA approval for a generic version of the drug. Item
>Pfizer closed to the media a Tuesday political candidates forum that the company is jointly sponsoring with the Connecticut Business and Industry Association. Report
> Shares in Novo Nordisk extended earlier losses amid concerns the world's largest insulin maker could face rising competition from cheap new diabetes drugs. News
Biotech News
@FierceBiotech: Sanofi will attend Harvard in hunt for new blockbusters. Article| Follow @FierceBiotech
@JohnCFierce:Peregrine brain cancer drug more than triples survival rate--vs non-treatment--for 14 patients in mid-stage study. Article | Follow @JohnCFierce
> Study: That 'placebo effect' may have a hidden meaning. News
> Why are women thriving in the top ranks of biotech? Article
> Pearl lands $69M Series C for mid-stage COPD program. Report
> Transcept readies second attempt at sleep drug approval. Story
> Pfizer's new biosimilar insulin pact dents high-flying Novo. Article
Biotech Research News
> GSK sees new value in treatments for rare diseases. Article
> Urine test could predict prostate cancer. News
> Wellcome Trust worries about immigration laws. Story
> Ovarian cancer detection study disputed. Report
> A PiggyBac ride to genetic causes of cancer. Article
> New technique may increase healthy IVF births. News
Manufacturing News
> Teva finds regulatory VP at FDA gate. Story
> FDA probes SPL over contaminated heparin. News
> GAO joins FDA in congressional spotlight. Report
> Hackers hijack Microsoft's servers for fake-drug spam. Item
> Compliance packaging to benefit from healthcare reform. Story
And Finally... Bayer's Factor Xa anticoagulant Xarelto scooped the Best Pharmaceutical Agent award at the prestigious Prix Galien ceremony. Report